Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis

被引:6
作者
Zubatkina, Irina [1 ]
Ivanov, Pavel [1 ,2 ]
机构
[1] Stereotact Radiotherapy & Gen Oncol Clin MIBS, Dept Radiosurg, 43 Karla Marksa Str, St Petersburg 197758, Russia
[2] Polenov Russian Sci Res Inst Neurosurg, Branch Fed Almazov North West Med Res Ctr, Dept Neurooncol, St Petersburg, Russia
关键词
melanoma; brain metastases; radiosurgery; imaging response; prognosis; oncology; stereotactic radiosurgery; GAMMA-KNIFE RADIOSURGERY; STEREOTACTIC RADIOSURGERY; VOLUMETRIC RESPONSE; RADIATION-THERAPY; MANAGEMENT; CELL; SURVIVAL; BIOLOGY;
D O I
10.3171/2017.1.JNS162075
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The aim of this study was to analyze the early radiological response of melanoma brain metastases to single high-dose irradiation and to reveal possible correlations between tumor radioresponsiveness and patient clinical outcomes. METHODS The authors performed a retrospective analysis of the medical data for all patients with melanoma brain metastases who had undergone Gamma Knife radiosurgery (GKRS) and follow-up MRI examinations with standard protocols at regular 2-to 3-month intervals. Volumetric measurements of the metastases on pretreatment and initial post-treatment images were performed to assess the rate of early radiological response. Patients were divided into 2 groups according to the rate of response, and overall survival, local control, and the appearance of new metastases in the brain were compared in these groups using the long-rank test. Univariate and multivariate analyses were performed to identify predictors of clinical outcomes. RESULTS After retrospective analysis of 298 melanoma brain metastases in 78 patients, the authors determined that early radiological responses of these metastases to GKRS differ considerably and can be divided into 2 distinct groups. One group of tumors underwent rapid shrinkage after radiosurgery, whereas the other showed minor fluctuations in size (rapid-and slow-response groups, respectively). Median survival for patients with a slow response was 15.2 months compared with 6.3 months for those with a rapid response (p < 0.0001). In the multivariate analysis, improved overall survival was associated with a slow response to radiosurgery (p < 0.0001), stable systemic disease (p = 0.001), and a higher Karnofsky Performance Scale score (p = 0.001). Stratification by Recursive Partitioning Analysis, score index for radiosurgery, and diagnosis-specific Graded Prognostic Assessment classes further confirmed the difference in overall survival for patients with a slow versus rapid radiation response. Local recurrence was observed in 11% of patients with a rapid response and in 6% of patients with a slow response, at a median of more than 8 months after radiosurgery. New brain metastases were diagnosed in 67% of patients with a slow response at a median of 8.6 months after radiosurgery and in 82% of patients with a rapid response at a considerably earlier median time of 2.7 months. In the multivariate analysis, a longer time to the development of new brain metastases was associated with a slow response (p = 0.012), stable systemic disease (p = 0.034), and a single brain metastasis (p = 0.030). CONCLUSIONS Melanoma brain metastases show different early radioresponsiveness to radiosurgery. Rapid shrinkage of brain metastases is associated with poor patient prognosis, which may indicate more aggressive biological behavior of this tumor phenotype.
引用
收藏
页码:354 / 365
页数:12
相关论文
共 38 条
  • [1] Why is melanoma so metastatic?
    Braeuer, Russell R.
    Watson, Ian R.
    Wu, Chang-Jiun
    Mobley, Aaron K.
    Kamiya, Takafumi
    Shoshan, Einav
    Bar-Eli, Menashe
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (01) : 19 - 36
  • [2] Brown PD, 2008, NEUROSURGERY, V62, P790, DOI [10.1227/01.NEU.0000023713.44940.20, 10.1227/01.neu.0000316283.45242.e1]
  • [3] Tumor exploits alternative strategies to achieve vascularization
    Bussolati, Benedetta
    Grange, Cristina
    Camussi, Giovanni
    [J]. FASEB JOURNAL, 2011, 25 (09) : 2874 - 2882
  • [4] Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases
    Chowdhury, Imran H.
    Ojerholm, Eric
    McMillan, Matthew T.
    Miller, Denise
    Kolker, James D.
    Kurtz, Goldie
    Dorsey, Jay F.
    Nagda, Suneel N.
    Geiger, Geoffrey A.
    Brem, Steven
    O'Rourke, Donald M.
    Zager, Eric L.
    Gangadhar, Tara
    Schuchter, Lynn
    Lee, John Y. K.
    Alonso-Basanta, Michelle
    [J]. RADIATION ONCOLOGY, 2015, 10
  • [5] The biology of melanoma brain metastasis
    Fidler, IJ
    Schackert, G
    Zhang, R
    Radinsky, R
    Fujimaki, T
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (03) : 387 - 400
  • [6] Advances in therapy for melanoma brain metastases
    Flanigan, Jaclyn C.
    Jilaveanu, Lucia B.
    Chiang, Veronica L.
    Kluger, Harriet M.
    [J]. CLINICS IN DERMATOLOGY, 2013, 31 (03) : 264 - 281
  • [7] Engaging the vascular component of the tumor response
    Fuks, Z
    Kolesnick, R
    [J]. CANCER CELL, 2005, 8 (02) : 89 - 91
  • [8] Tumor response to radiotherapy regulated by endothelial cell apoptosis
    Garcia-Barros, M
    Paris, F
    Cordon-Cardo, C
    Lyden, D
    Rafii, S
    Haimovitz-Friedman, A
    Fuks, Z
    Kolesnick, R
    [J]. SCIENCE, 2003, 300 (5622) : 1155 - 1159
  • [9] Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
    Gaspar, L
    Scott, C
    Rotman, M
    Asbell, S
    Phillips, T
    Wasserman, T
    McKenna, WG
    Byhardt, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04): : 745 - 751
  • [10] Gamma-knife radiosurgery in the management of melanoma patients with brain metastases: A series of 106 patients without whole-brain radiotherapy
    Gaudy-Marqueste, Caroline
    Regis, Jean-Marie
    Muracciole, Xavier
    Laurans, Renaud
    Richard, Marie-Aleth
    Bonerandi, Jean-Jacques
    Grob, Jean-Jacques
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 809 - 816